Internationally recognized expert in the field of influenza viral genomics and diagnostics. Responsible for Manufacturing and Maintaining 6 FDA approved diagnostic assays including CDC’s Influenza A/B SARS-CoV-2 Multiplex Assay. Sequenced and published first RNA genome by sequencing the viral RNA directly. Team is one of the largest producers of influenza genomic data in the world.
This panel will discuss the current state of affairs for virus testing including genotyping, antigen testing including limitations, and the value for antibody testing including total, virus neutralization, and surrogate neutralization testing in light of COVID variants. Also cover home testing options and limitations.